Skip to main content
SpringerLink
Log in

Radiobiology: Concepts and Basic Principles

  • Chapter
  • First Online:
Basic Sciences of Nuclear Medicine

  • 2683 Accesses

Abstract

Very soon after the discovery of radiation and radioactivity short- and long-term negative effects of radiation on human tissue were observed. Adverse effects of X-rays were observed by Thomas Edison, William J. Morton, and Nikola Tesla; they independently reported eye irritations from experimentation with X-rays and fluorescent substances. These effects were thought to be eye strain, or possibly due to exposure to ultraviolet radiation. Elihu Thomson (an American physicist) deliberately exposed the little finger of his left hand to X-rays for several days, for a short time each day, and observed pain, swelling, stiffness, erythema, and blistering in the finger, which was clearly and immediately related to the radiation exposure. William Herbert Rollins (a Boston dentist) demonstrated that X-rays could kill guinea pigs and result in the death of offspring when guinea pigs were irradiated while pregnant. Henri Becquerel received a skin burn from a radium source given to him by the Curies that he carried in a vest pocket at times. He once was reported to have said: “I love this radium but I have a grudge against it!” The first death in an X-ray pioneer attributed to cumulative overexposure was to C.M. Dally in 1904. Radiologists and other physicians who used X-rays in their practices before health physics practices were common had a significantly higher rate of leukemia than their colleagues. A particularly tragic episode in the history of the use of radiation and in the history of industrialism was the acute and chronic biological damage suffered by the Radium Dial Painters [1]. Radium was used in luminous paints in the early 1900s. In factories where luminous dial watches were made, workers (mainly women) would sharpen the tips of their paint brushes with their lips, and thus ingested large amounts of radium. They had increased amounts of bone cancer (carcinomas in the paranasal sinuses or the mastoid structures, which are very rare, and were thus clearly associated with their exposures, as well as cancers in other sites) and even spontaneous fractures in their jaws and spines from cumulative radiation injury. Others died of anemia and other causes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mullner R (1989) Deadly glow. The radium dial worker tragedy. American Public Health Association, Washington DC

    Google Scholar 

  2. Bergonie J, Tribondeau L (1906) De quelques resultats de la Radiotherapie, et esaie de fixation d’une technique rationelle. Comptes Rendu des Seances de l’Academie des Sciences 143:983–985

    Google Scholar 

  3. Jonah CD, Miller JR (1977) Yield and decay of the OH radical from 100 ps to 3 ns. J Phys Chem 81:1974–1976

    Article  CAS  Google Scholar 

  4. Sachs RK, Hahnfeld P, Brenner DJ (1997) The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol 72:351–374

    Article  PubMed  CAS  Google Scholar 

  5. Lea DE, Catcheside DG (1942) The mechanism of the induction by radiation of chromosome abberations in tradescantia. J Genet 44:216–245

    Article  Google Scholar 

  6. Barendson GW (1982) Dose fractionation, dose-rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8:1981–1987

    Article  Google Scholar 

  7. Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679–694

    Article  PubMed  CAS  Google Scholar 

  8. Bodey RK, Evans PM, Flux GD (2004) Application of the linear-quadratic model to combined modality radiotherapy. Int J Radiat Oncol Biol Phys 59(1):228–241

    Article  PubMed  Google Scholar 

  9. Pimblott SM, LaVerne JA (1997) Stochastic simulation of the electron radiolysis of water and aqueous solutions. J Phys Chem A 101:5828–5838

    Article  CAS  Google Scholar 

  10. Becker D, Sevilla MD, Wang W, LaVere T (1997) The role of waters of hydration in direct-effect radiation damage to DNA. Radiat Res 148:508–510

    CAS  Google Scholar 

  11. Wright HA, Magee JL, Hamm RN, Chatterjee A, Turner JE, Klots CE (1985) Calculations of physical and chemical reactions produced in irradiated water containing DNA. Radiat Prot Dosimetry 13:133–136

    CAS  Google Scholar 

  12. Turner JE, Hamm RN, Ritchie RH, Bolch WE (1994) Monte Carlo track-structure calculations for aqueous solutions containing biomolecules. Basic Life Sci 63:155–166

    PubMed  CAS  Google Scholar 

  13. Hall Eric J (2003) The Bystander effect. Health Phys 85(1):31–35

    Article  PubMed  CAS  Google Scholar 

  14. Maxon HR, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS et al (1992) Radioiodine-131 therapy for well-differentiated thyroid-cancer – a quantitative radiation dosimetric approach – outcome and validation in 85 patients. J Nucl Med 33(6):1132–1136

    PubMed  Google Scholar 

  15. Maxon HR (1999) Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med 43(4):313–323

    PubMed  CAS  Google Scholar 

  16. Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H (2008) Graves’ disease and radioiodine therapy: is success of ablation dependent on the achieved dose above 200 Gy? Nuklearmedizin 47(1):13–17

    PubMed  CAS  Google Scholar 

  17. Canzi C, Zito F, Voltini F, Reschini E, Gerundini P (2006) Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients. Med Phys 33(8):2860–2867

    Article  PubMed  CAS  Google Scholar 

  18. Carlier T, Salaun PY, Cavarec MB, Valette F, Turzo A, Bardies M, Bizais Y, Couturier O (2006) Optimized radioiodine therapy for Graves’ disease: two MIRD-based models for the computation of patient-specific therapeutic I-131 activity. Nucl Med Commun 27(7):559–566

    Article  PubMed  CAS  Google Scholar 

  19. Grosso M, Traino A, Boni G, Banti E, Della Porta M, Manca G, Volterrani D, Chiacchio S, AlSharif A, Borso E, Raschilla R, Di Martino F, Mariani G (2005) Comparison of different thyroid committed doses in radioiodine therapy for Graves’ hyperthyroidism. Cancer Biother Radiopharm 20(2):218–223

    Article  PubMed  CAS  Google Scholar 

  20. Dorn R, Kopp J, Vogt H, Heidenreich P, Carroll RG, Gulec SA (2003) Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose sing a risk-adapted approach. J Nucl Med 44:451–456

    PubMed  CAS  Google Scholar 

  21. Jonsson H, Mattsson S (2004) Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism. Radiat Prot Dosim 108(2):107–114

    Article  Google Scholar 

  22. Pauwels S, Barone R, Walrand S, Borson-Chazot F, Valkema R, Kvols LK, Krenning EP, Jamar F (2005) Practical dosimetry of peptide receptor radionuclide therapy with 90Y-labeled somatostatin analogs. J Nucl Med 46(1(Suppl)):92S–98S

    PubMed  CAS  Google Scholar 

  23. Furhang EE, Larson SM, Buranapong P, Humm JL (1999) Thyroid cancer dosimetry using clearance fitting. J Nucl Med 40(1):131–136

    PubMed  CAS  Google Scholar 

  24. Maxon HR, Thomas SR, Samaratunga RC (1997) Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer. Thyroid 7(2):183–187

    Article  PubMed  CAS  Google Scholar 

  25. Monsieurs M, Brans B, Bacher K, Dierckx R, Thierens H (2002) Patient dosimetry for I-131-MIBG therapy for neuroendocrine tumours based on I-123-MIBG scans. Eur J Nucl Med Mol Imaging 29(12):1581–1587

    Article  PubMed  CAS  Google Scholar 

  26. Flux GD, Guy MJ, Papavasileiou P, South C, Chittenden SJ, Flower MA, Meller ST (2003) Absorbed dose ratios for repeated therapy of neuroblastoma with I-131 mIBG. Cancer Biother Radiopharm 18(1):81–87

    Article  PubMed  CAS  Google Scholar 

  27. DeNardo GL, DeNardo SJ, Shen S, DeNardo DA, Mirick GR, Macey DJ, Lamborn KR (1999) Factors affecting I-131-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. J Nucl Med 40(8):1317–1326

    PubMed  CAS  Google Scholar 

  28. Linden O, Tennvall J, Cavallin-Stahl E, Darte L, Garkavij M, Lindner KJ, Ljungberg M, Ohlsson T, Sjogreen K, Wingardh K, Strand SE (1999) Radioimmunotherapy using I-131-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas. Clin Cancer Res 5(10):3287S–3291S

    PubMed  CAS  Google Scholar 

  29. Chatal JF, FaivreChauvet A, Bardies M, Peltier P, Gautherot E, Barbet J (1995) Bifunctional antibodies for radioimmunotherapy. Hybridoma 14(2):125–128

    Article  PubMed  CAS  Google Scholar 

  30. Wahl RL, Kroll S, Zasadny KR (1998) Patient-specific whole-body dosimetry: principles and a simplified method for clinical implementation. J Nucl Med 39(8):14S–20S

    PubMed  CAS  Google Scholar 

  31. Wiseman GA, White CA, Sparks RB, Erwin WD, Podoloff DA, Lamonica D, Bartlett NL, Parker JA, Dunn WL, Spies SM, Belanger R, Witzig TE, Leigh BR (2001) Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B- cell non-Hodgkin’s lymphoma. Crit Rev Oncol Hematol 39(1–2):181–194

    Article  PubMed  CAS  Google Scholar 

  32. Cremonesi M, Ferrari M, Chinol M, Bartolomei M, Stabin MG, Sacco E, Fiorenza M, Tosi G, Paganelli G (2000) Dosimetry in radionuclide therapies with Y-90-conjugates: the IEO experience. Q J Nucl Med 44(4):325–332

    PubMed  CAS  Google Scholar 

  33. Barone R, Walrand S, Valkema R, Kvols L, Smith C, Krenning EP, Jamar F, Pauwels S (2002) Correlation between acute red marrow (RM) toxicity and RM exposure during Y-90-SMT487 therapy. J Nucl Med 43:1267

    Google Scholar 

  34. Stabin MG (2008) The case for patient-specific dosimetry in radionuclide therapy. Cancer Biother Radiopharm 23(3): 273–284

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Radiological Sciences, Vanderbilt University, 1161 21st Avenue South, Nashville, TN, 37232–2675, USA

    Michael G. Stabin

Authors
  1. Michael G. Stabin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael G. Stabin .

Editor information

Editors and Affiliations

  1. Hammersmith Campus, Biological Imaging Centre, Imperial College London, Du Cane Road, London, W12 0NN, United Kingdom

    Magdy M. Khalil

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Stabin, M.G. (2010). Radiobiology: Concepts and Basic Principles. In: Khalil, M. (eds) Basic Sciences of Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85962-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-85962-8_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-85961-1

  • Online ISBN: 978-3-540-85962-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation